1. SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review

   • Gabriele Imbalzano
   • Claudia Ledda
   • Maurizio Zibetti

   COVID-19 06 June 2022 Pages: 5165 - 5168

2. Stroke admissions during the COVID-19 pandemic: a single-center retrospective analysis

   • Marina Padroni
   • Michele Laudisi
   • Ilaria Casetta

   COVID-19 20 June 2022 Pages: 5169 - 5174

3. Prevalence, characteristics and risk factors in a Moroccan cohort of Long-Covid-19

   • Hicham El Otmani
   • Salma Nabili
   • Mohammed Abdoh Rafai

   COVID-19 25 May 2022 Pages: 5175 - 5180

4. COVID-19 infection and Down syndrome—challenges and future directions for care in children

   • Kaushambi Chauhan
   • Rama Alkhaldi
   • Surobhi Chatterjee

   COVID-19 29 June 2022 Pages: 5181 - 5182

5. The use of corticosteroids in patients with COVID-19 vaccine–related cerebral venous thrombosis

   • Chia Siang Kow
   • Dinesh Sangarran Ramachandram
   • Syed Shahzad Hasan

   COVID-19 01 June 2022 Pages: 5183 - 5184

6. A mild course of COVID-19 infection in a generalized Myasthenia gravis patient under eculizumab treatment

   • Ceren Alis
   • Dogukan Hazar Emre
   • Nurten Uzun Adatepe

   COVID-19 08 May 2022 Pages: 5185 - 5187

7. Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis

   • Nan Hu
   • Hongyan Ji

   Review Article 26 May 2022 Pages: 5189 - 5199

   

8. Parkinsonism in idiopathic normal pressure hydrocephalus: is it time for defining a clinical tetrad?

   • Giovanni Mostile
   • Alfonso Fasano
   • Mario Zappia

   Review Article Open access 01 June 2022 Pages: 5201 - 5205

9. Reporting of “usual care” as the control group in randomized clinical trials of physiotherapy interventions for multiple sclerosis is poor: a systematic review

   • Matteo Paci
   • Federico Risaliti
   • Leonardo Pellicciari

   Review Article 31 May 2022 Pages: 5207 - 5216

   

10. Side effects of long-term oral anti-seizure drugs on thyroid hormones in patients with epilepsy: a systematic review and network meta-analysis

    • Yujuan Han
    • Jiaxin Yang
    • Weihong Lin

    Review Article 30 May 2022 Pages: 5217 - 5227

    

11. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis

    • Sara Gasparini
    • Sabrina Neri
    • Epilepsy Study Group of the Italian Neurological Society

    Review Article 31 May 2022 Pages: 5229 - 5236

    

12. Autoimmune encephalitis and CSF anti-AMPA GluR3 antibodies in childhood: a case report and literature review

    • Maria Elena Cucuzza
    • Piero Pavone
    • Vita Antonella Di Stefano

    Review Article 31 May 2022 Pages: 5237 - 5241

    

13. A rank subdivision of equivalent score for enhancing neuropsychological test norms

    • Alessio Facchin
    • Ezia Rizzi
    • Michela Vezzoli

    Original Article Open access 17 May 2022 Pages: 5243 - 5249

    

14. Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status

    • Sofia Cuoco
    • Roberto Erro
    • Paolo Barone

    Original Article Open access 30 May 2022 Pages: 5251 - 5258

    

15. The pupil and myself: pupil dilation during retrieval of self-defining memories

    • Mohamad El Haj
    • Quentin Lenoble
    • Ahmed A. Moustafa

    Original Article 30 May 2022 Pages: 5259 - 5265

    

16. Development of an Italian version of the functional communication measures and preliminary observations in patients with severe acquired brain injury and emerging from a prolonged disorder of consciousness

    • Francesco De Bellis
    • Alfonso Magliacano
    • Anna Estraneo

    Original Article 03 June 2022 Pages: 5267 - 5273

17. Pure word deafness: a case report of an atypical manifestation of Alzheimer’s disease

    • Simone Salemme
    • Francesca Benuzzi
    • Annalisa Chiari

    Original Article 17 June 2022 Pages: 5275 - 5279

    

18. Sex influences clinical phenotype in frontotemporal dementia

    • Marta Pengo
    • Antonella Alberici
    • Barbara Borroni

    Original Article Open access 08 June 2022 Pages: 5281 - 5287

    

19. Genetic landscape of early-onset dementia in Hungary

    • Dora Csaban
    • Anett Illes
    • Maria Judit Molnar

    Original Article Open access 25 June 2022 Pages: 5289 - 5300

20. Polymorphism of neurodegeneration-related genes associated with Parkinson’s disease risk

    • Jiaxin Li
    • Minhan Yi
    • Yuan Zhang

    Original Article 13 June 2022 Pages: 5301 - 5312

    

21. Neurocognitive correlates of numerical abilities in Parkinson’s disease

    • Francesca Burgio
    • Nicola Filippini
    • Giorgio Arcara

    Original Article 23 June 2022 Pages: 5313 - 5322

    

22. Cerebral blood flow alterations specific to freezing of gait in Parkinson’s disease

    • Shangpei Wang
    • Tong Wu
    • Yongqiang Yu

    Original Article 20 June 2022 Pages: 5323 - 5331

    

23. FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice

    • Annachiara Arnone
    • Michela Allocca
    • Valentina Berti

    Original Article Open access 14 June 2022 Pages: 5333 - 5341

    

24. Lower serum triglyceride levels linked to more severe motor performance in Parkinson’s disease

    • Meimei Zhang
    • Huimin Chen
    • Yumei Zhang

    Original Article Open access 24 May 2022 Pages: 5343 - 5353

    

25. Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence

    • Claudio Liguori
    • Mariana Fernandes
    • Mariangela Pierantozzi

    Original Article Open access 10 May 2022 Pages: 5355 - 5362

26. Episodic memory in progressive supranuclear palsy: a neuropsychological and neuroimaging study

    • Arthur Cassa Macedo
    • Paulo Caramelli
    • Leonardo Cruz de Souza

    Original Article 28 May 2022 Pages: 5363 - 5368

    

27. The Italian tremor Network (TITAN): rationale, design and preliminary findings

    • Roberto Erro
    • Andrea Pilotto
    • TITAN Study Group

    Original Article Open access 24 May 2022 Pages: 5369 - 5376

28. Predictive value of quantitative pupillometry in patients with normal pressure hydrocephalus undergoing temporary CSF diversion

    • Bethany L. Lussier
    • Melissa Erapuram
    • DaiWai M. Olson

    Original Article 25 June 2022 Pages: 5377 - 5382

29. Incipient chronic traumatic encephalopathy in active American football players: neuropsychological assessment and brain perfusion measures

    • Giacomo Querzola
    • Carlo Lovati
    • Leonardo Pantoni

    Original Article Open access 24 June 2022 Pages: 5383 - 5390

    

30. OPTN variants in ALS cases: a case report of a novel mutation and literature review

    • Yan Mou
    • Min Li
    • Yunhong Zha

    Original Article 04 June 2022 Pages: 5391 - 5396

    

31. Cognition and motor phenotypes in ALS: a retrospective study

    • Edoardo Nicolò Aiello
    • Debora Pain
    • Gabriele Mora

    Original Article Open access 24 May 2022 Pages: 5397 - 5402

    

32. Alteration of interoceptive sensitivity: expanding the spectrum of behavioural disorders in amyotrophic lateral sclerosis

    • Pasquale Moretta
    • Myriam Spisto
    • Raffaele Dubbioso

    Original Article Open access 25 June 2022 Pages: 5403 - 5410

    

33. Accuracy of Dysphagia Standard Assessment (DSA®) bedside screening test: a flowchart for patient eligibility

    • Laura Mariani
    • Armando Cilfone
    • Giovanni Ruoppolo

    Original Article Open access 04 June 2022 Pages: 5411 - 5419

    

34. HR-MRI findings of intracranial artery stenosis and distribution of atherosclerotic plaques caused by different etiologies

    • Jie Sun
    • Xu-Ran Feng
    • Tian-Zi Zhang

    Original Article 26 May 2022 Pages: 5421 - 5430

    

35. Elevated troponin I levels on admission predict long-term mortality in patients with acute cerebral infarction following thrombolysis

    • Yuehong Huang
    • Yanqi Shao
    • Tianming Shi

    Original Article Open access 17 May 2022 Pages: 5431 - 5439

    

36. Anti-seizure medication treatment and outcomes in acute ischemic stroke patients undergoing continuous EEG monitoring

    • Paula R. Sanches
    • Mohammad Tabaeizadeh
    • Sahar F. Zafar

    Original Article 17 June 2022 Pages: 5441 - 5449

    

37. Challenges of practicing neuro-endovascular interventions in a resource-limited country; Ghana in focus

    • Benjamin Dabo Sarkodie
    • Bashiru Babatunde Jimah
    • Edmund Kwakye Brakohiapa

    Original Article 22 June 2022 Pages: 5451 - 5457

    

38. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

    • Roberto Bergamaschi
    • Ettore Beghi
    • Giancarlo Comi

    Original Article Open access 07 June 2022 Pages: 5459 - 5469

    

39. Cross-cultural adaptation, validation, and the reliability of the Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis

    • Fatih Özden
    • Mehmet Özkeskin
    • Nur Yüceyar

    Original Article 09 June 2022 Pages: 5471 - 5477

40. Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis

    • Katarzyna Śladowska
    • Paweł Kawalec
    • Oktawia Osiecka

    Original Article 17 June 2022 Pages: 5479 - 5500

    

41. Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review

    • Maria Pia Giannoccaro
    • Eleonora Matteo
    • Giovanni Rizzo

    Original Article 21 May 2022 Pages: 5501 - 5511

    

42. Concurrent CNS tumors and multiple sclerosis: retrospective single-center cohort study and lessons for the clinical management

    • Yavor Yalachkov
    • Dilara Dabanli
    • Martin Voss

    Original Article Open access 19 May 2022 Pages: 5513 - 5522

    

43. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients

    • Xiaohan Shi
    • ·Huayu Li
    • ·Feng Li

    Original Article 23 May 2022 Pages: 5523 - 5531

    

44. Recurrent glioblastoma: which treatment? A real-world study from the Neuro-oncology Unit “Regina Elena” National Cancer Institute

    • Veronica Villani
    • Luca Prosperini
    • Andrea Pace

    Original Article 31 May 2022 Pages: 5533 - 5541

    

45. Global and local shape features of the hippocampus based on Laplace–Beltrami eigenvalues and eigenfunctions: a potential application in the lateralization of temporal lobe epilepsy

    • Rosita Shishegar
    • Ziba Gandomkar
    • Hamid Soltanian-Zadeh

    Original Article 22 June 2022 Pages: 5543 - 5552

    

46. Significance and clinical suggestions for the somatosensory evoked potentials increased in amplitude revealed by a large sample of neurological patients

    • Davide Rossi Sebastiano
    • Daniele Cazzato
    • Paola Lanteri

    Original Article 27 June 2022 Pages: 5553 - 5562

    

47. Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort

    • Carlotta Mutti
    • Valerio Brunetti
    • Giuseppe Plazzi

    Original Article Open access 25 June 2022 Pages: 5563 - 5574

    

48. Higher basophil count decreases narcolepsy risk: a Mendelian randomization study

    • Ang Li
    • Hao Li
    • Xiaowen Zhang

    Original Article 12 May 2022 Pages: 5575 - 5580

    

49. Leber’s hereditary optic neuropathy plus dystonia caused by the mitochondrial ND1 gene m.4160 T > C mutation

    • Hong Ren
    • Yan Lin
    • Chuanzhu Yan

    Original Article 14 June 2022 Pages: 5581 - 5592

    

50. Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review

    • Noushin Rostampour
    • Rojin Chegini
    • Mahin Hashemipour

    Original Article 21 June 2022 Pages: 5593 - 5603